-
2024Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2., iScience 2024 Jul; 27(7): 110354.
-
2024Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus., Cell 2024 Jun; (): .
-
2024Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling., Nat Commun 2024 Jun; 15(1): 4996.
-
2024Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion., Nat Commun 2024 Mar; 15(1): 2254.
-
2023High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1., J Virol 2023 Dec; (): e0135123.
-
2023TMPRSS2 is a functional receptor for human coronavirus HKU1., Nature 2023 Oct; (): .
-
2023Dissecting human population variation in single-cell responses to SARS-CoV-2, Nature, 2023, 53 (8), pp.e2250307. ⟨10.1038/s41586-023-06422-9⟩.
-
2023Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals., Cell Host Microbe 2023 Jun; 31(6): 937-948.e4.
-
2023Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
-
2023Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4+ T Cells., Microbiol Spectr 2023 Feb; (): e0431322.
-
2023Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies., Nat Commun 2023 Feb; 14(1): 824.
-
2022Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity., Nat Commun 2022 Nov; 13(1): 7254.
-
2022Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies., Cell Rep Med 2022 Nov; (): 100850.
-
2022Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection., Med (N Y) 2022 Dec; 3(12): 838-847.e3.
-
2022Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
-
2022IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies., Eur J Immunol 2022 Aug; (): .
-
2022Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status., Elife 2022 Jul; 11(): .
-
2022Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1., iScience 2022 Jul; 25(7): 104599.
-
2022C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus., iScience 2022 Jul; 25(7): 104537.
-
2022Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
-
2022Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2., J Exp Med 2022 Jul; 219(7): .
-
2022Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies., Nat Med 2022 Jun; 28(6): 1297-1302.
-
2022Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen., Nat Commun 2022 05; 13(1): 2442.
-
2022Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers., Nat Commun 2022 Apr; 13(1): 1944.
-
2022Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2., EBioMedicine 2022 Mar; 77(): 103934.
-
2022Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller., J Exp Med 2022 Mar; 219(3): .
-
2022Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells., Nat Commun 2022 02; 13(1): 630.
-
2022Considerable escape of SARS-CoV-2 Omicron to antibody neutralization., Nature 2022 Feb; 602(7898): 671-675.
-
2022Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry., Nat Commun 2022 Jan; 13(1): 521.
-
2022Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort., Front Immunol 2022 ; 13(): 817905.
-
2021Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study., EBioMedicine 2021 Nov; 73(): 103637.
-
2021Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2., J Infect Dis 2021 09; 224(6): 983-988.
-
2021Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection., Nat Immunol 2021 Sep; 22(11):1428-1439.
-
2021Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission., J Biol Chem 2021 10; 297(4): 101098.
-
2021A monocyte/dendritic cell molecular signature of SARS-CoV-2 related multisystem inflammatory syndrome in children (MIS-C) with severe myocarditis., Med (N Y) 2021 Aug; (): .
-
2021Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual., Open Forum Infect Dis 2021 Aug; 8(8): ofab369.
-
2021Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection., Sci Adv 2021 08; 7(34): .
-
2021Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2., Science 2021 07; 373(6554): 541-547.
-
2021SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells., Nat Commun 2021 07; 12(1): 4582.
-
2021Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic., Br J Dermatol 2021 Jul; (): .
-
2021Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization., Nature 2021 08; 596(7871): 276-280.
-
2021Pregnancy complications and Interferon-induced transmembrane proteins (IFITM): balancing antiviral immunity and placental development., C R Biol 2021 Jul; 344(2): 145-156.
-
2021Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 05; 2(5): 100275.
-
2021SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020, Eurosurveillance, 2021, 26 (15), pp.2001695. ⟨10.2807/1560-7917.es.2021.26.15.2001695⟩.
-
2021Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers., Nat Commun 2021 02; 12(1): 844.
-
2021Syncytia formation by SARS-CoV-2-infected cells., EMBO J 2021 Feb; 40(3): e107405.
-
2021IgA dominates the early neutralizing antibody response to SARS-CoV-2., Sci Transl Med 2021 01; 13(577): .
-
2021Characteristics Associated with Olfactory and Taste Disorders in COVID-19., Neuroepidemiology 2021 ; 55(5): 381-386.
-
2020Syncytia formation by SARS-CoV-2-infected cells., EMBO J 2020 12; 39(23): e106267.
-
2020Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier., mBio 2020 Oct; 11(5): .
-
2020A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations, Science Translational Medicine, 2020, 12 (559), pp.eabc3103. ⟨10.1126/scitranslmed.abc3103⟩.
-
2020Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France., EBioMedicine 2020 Sep; 59(): 102915.
-
2020Efficacy of Ultrasound for Localized Fat Treatment on Clinical and Psychological Outcomes: A Randomized, Single-Blind, Placebo-Controlled Clinical Trial., Aesthet Surg J Open Forum 2020 Jun; 2(2): ojaa012.
-
2020Remodeling of the Core Leads HIV-1 Preintegration Complex into the Nucleus of Human Lymphocytes., J Virol 2020 05; 94(11): .
-
2020Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells., EMBO Rep 2020 02; 21(2): e49351.
-
2020Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein., Nat Commun 2020 01; 11(1): 596.
-
2019X-ray Structures of the Post-fusion 6-Helix Bundle of the Human Syncytins and their Functional Implications., J Mol Biol 2019 12; 431(24): 4922-4940.
-
2019The Atlastin ER-shaping proteins facilitate Zika virus replication, Journal of Virology, 2019, 93 (23), pp.e01047-19. ⟨10.1128/JVI.01047-19⟩.
-
2019IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise., Science 2019 Jul; 365(6449): 176-180.
-
2019Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations, PLoS Pathog. 2019 Jun;15(6):e1007868.
-
2019HIV-1 Envelope FRETted Over by Antibodies, Cell Host Microbe 2019 06;25(6):767-768.
-
2019Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice., Eur J Immunol 2019 06; 49(6): 954-965.
-
2019HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells, Cell Rep 2019 Apr;27(2):572-585.e7.
-
2018Markers of the HIV-1 reservoir: facts and controversies, Curr Opin HIV AIDS 2018 Sep;13(5):383-388.
-
2018A human immune system mouse model with robust lymph node development., Nat Methods 2018 08; 15(8): 623-630.
-
2018HIV-1 cell-to-cell transmission and broadly neutralizing antibodies, Retrovirology 2018 07;15(1):51.
-
2018Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity, Cell Rep 2018 May;23(9):2568-2581.
-
2017More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins, Retrovirology 2017 Nov;14(1):53.
-
2017HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels, J. Virol. 2017 Nov;91(21).
-
2017IFITM3 requires an amphipathic helix for antiviral activity, EMBO Rep. 2017 Aug;.
-
2017HEXIM1 and NEAT1 Long Non-coding RNA Form a Multi-subunit Complex that Regulates DNA-Mediated Innate Immune Response, Mol. Cell 2017 Jul;.
-
2017Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells., EMBO J. 2017 06; 36(12): 1653-1668.
-
2017Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents., J Virol 2017 03; 91(6): .
-
2017CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses, Nature 2017 Mar;543(7646):564-567.
-
2017Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement, Nat Commun 2017 02;8:14253.
-
2017They Might Be Giants: Does Syncytium Formation Sink or Spread HIV Infection?, PLoS Pathog. 2017 Feb;13(2):e1006099.
-
2017Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies, J. Virol. 2017 Apr;91(8).
-
2017SUN2 silencing impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection independently of Cyclophilin A, J. Virol. 2017 Jan;.
-
2017Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses., Cell Rep 2017 01; 18(2): 324-333.
-
2016CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge, Sci Rep 2016 Oct;6:34829.
-
2016[Antibodies that kill HIV-1-infected cells], Med Sci (Paris) 2016 8-9;32(8-9):671-4.
-
2016Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity, EMBO Rep. 2016 Sep;.
-
2016[A mystery solved: HIV-1 Nef targets SERINC3 and SERINC5], Med Sci (Paris) 2016 Jun-Jul;32(6):560-2.
-
2016HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells, J. Immunol. 2016 Jul;197(2):517-32.
-
2016Elimination of HIV-1-infected cells by broadly neutralizing antibodies, Nat Commun 2016 Mar;7:10844.
-
2016Actin’ on HIV: How Dendritic Cells Spread Infection, Cell Host Microbe 2016 Mar;19(3):267-9.
-
2016SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV., J Virol 2016 Apr; 90(8): 4199-4214.
-
2016La famille des protéines IFITM : effets antiviraux et fonctions cellulaires, Virologie 2015, 19(6):251-60.
-
2015Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women, J. Immunol. 2015 Dec;195(11):5327-36.
-
2015The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection, J. Virol. 2015 Oct;.
-
2015Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells, J. Virol. 2015 Dec;89(23):12118-30.
-
2015Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway, PLoS Pathog. 2015 Aug;11(8):e1005091.
-
2015Human Immunodeficiency Virus-1 Cell-To-Cell Transmission And Antiviral Strategies: An Overview, Curr Drug Targets 2015 Aug;.
-
2015SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells, J. Virol. 2015 Jul;89(14):6994-7006.
-
2015Plasmacytoid Dendritic Cell Infection and Sensing Capacity during Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infection., J Virol 2015 Jul; 89(13): 6918-27.
-
2015Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1, AIDS 2015 Mar;29(5):519-30.
-
2015Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons, Sci Signal 2015 Mar;8(366):ra25.
-
2015Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation, J. Gen. Virol. 2015 Jun;96(Pt 6):1463-77.
-
2015HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells, Retrovirology 2015;12:2.
-
2014IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread, Cell Host Microbe 2014 Dec;16(6):736-47.
-
2014Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1., J Virol 2015 Jan; 89(2): 1329-39.
-
2014[HIV-1 cell-to-cell transmission and broadly neutralizing antibodies], Med Sci (Paris) 2014 May;30(5):508-10.
-
2014Contrasted innate responses to two viruses in zebrafish: insights into the ancestral repertoire of vertebrate IFN-stimulated genes., J. Immunol. 2014 May; 192(9): 4328-41.
-
2014Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings, J. Infect. Dis. 2014 Aug;210(3):424-34.
-
2013Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission, J. Exp. Med. 2013 Dec;210(13):2813-21.
-
2013Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library, PLoS Negl Trop Dis 2013;7(10):e2471.
-
2013Gain-of-function research: unknown risks, Science 2013 Oct;342(6156):311.
-
2013Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish., PLoS Pathog. 2013 ; 9(9): e1003619.
-
2013The SAMHD1 knockout mouse model: in vivo veritas?, EMBO J. 2013 Sep;32(18):2427-9.
-
2013HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer, Retrovirology 2013;10:80.
-
2013Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses, PLoS ONE 2013;8(1):e52003.
-
2012SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells, J. Virol. 2013 Mar;87(5):2846-56.
-
2012Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles, Blood 2012 Dec;120(24):4744-50.
-
2012Restricting HIV the SAMHD1 way: through nucleotide starvation, Nat. Rev. Microbiol. 2012 Oct;10(10):675-80.
-
2012Chikungunya-induced cell death is limited by ER and oxidative stress-induced autophagy, Autophagy 2012 Aug;8(8):1261-3.
-
2012Hyperthermia stimulates HIV-1 replication, PLoS Pathog. 2012;8(7):e1002792.
-
2012Transcytosis of HTLV-1 across a tight human epithelial barrier and infection of subepithelial dendritic cells, Blood 2012 Jul;120(3):572-80.
-
2012[Generalized eruptive syringoma], Ann Dermatol Venereol 2012 Jun;139(6-7):508-9.
-
2012Chikungunya virus-induced autophagy delays caspase-dependent cell death, J. Exp. Med. 2012 May;209(5):1029-47.
-
2012Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection, J. Immunol. 2012 Apr;188(7):2967-71.
-
2011Innate sensing of foamy viruses by human hematopoietic cells, J. Virol. 2012 Jan;86(2):909-18.
-
2011Automated genome-wide visual profiling of cellular proteins involved in HIV infection, J Biomol Screen 2011 Oct;16(9):945-58.
-
2011A new role for the HTLV-1 p8 protein: increasing intercellular conduits and viral cell-to-cell transmission, Viruses 2011 Mar;3(3):254-9.
-
2011Innate sensing of HIV-infected cells, PLoS Pathog. 2011 Feb;7(2):e1001284.
-
2010HIV-1 Virological Synapse: Live Imaging of Transmission, Viruses 2010 Aug;2(8):1666-80.
-
2010Biology and pathogenesis of chikungunya virus, Nat. Rev. Microbiol. 2010 Jul;8(7):491-500.
-
2010Tetherin restricts productive HIV-1 cell-to-cell transmission, PLoS Pathog. 2010;6(6):e1000955.
-
2010Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect, J. Virol. 2010 May;84(10):5314-28.
-
2010Type I IFN controls chikungunya virus via its action on nonhematopoietic cells., J Exp Med 2010 Feb; 207(2): 429-42.
-
2009The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells, J. Exp. Med. 2010 Jan;207(1):39-49.
-
2009Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer, J. Virol. 2009 Oct;83(20):10527-37.
-
2009Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses, J. Virol. 2009 Jun;83(12):6234-46.
-
2009Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic, Virology 2009 May;388(1):191-203.
-
2007Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus, PLoS Negl Trop Dis 2007;1(3):e96.
-
2007Human muscle satellite cells as targets of Chikungunya virus infection, PLoS ONE 2007;2(6):e527.
-
2007Characterization of reemerging chikungunya virus, PLoS Pathog. 2007 Jun;3(6):e89.
-
2007Modulation of the immunological synapse: a key to HIV-1 pathogenesis?, Nat Rev Immunol. 2007 Apr;7(4):310-7.
-
2006Inefficient human immunodeficiency virus replication in mobile lymphocytes, J. Virol. 2007 Jan;81(2):1000-12.
-
2006DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells, J. Virol. 2006 May;80(10):4771-80.
-
2006Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse, Immunity 2006 May;24(5):547-61.
-
2006Restriction of foamy viruses by APOBEC cytidine deaminases, J. Virol. 2006 Jan;80(2):605-14.
-
2005DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis, PLoS Med. 2005 Dec;2(12):e381.
-
2005Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases, J. Gen. Virol. 2005 Sep;86(Pt 9):2489-94.
-
2005Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes, J. Virol. 2005 May;79(9):5386-99.
-
2004Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames, J. Exp. Med. 2004 Apr;199(8):1053-63.
-
2004Cell of the month. Dendritic cell sensing a lymphocyte, Nat. Rev. Mol. Cell Biol. 2004 Mar;5(3):175.
-
2004DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm., J Virol 2004 Jan; 78(2): 798-810.
-
2003DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation, Blood 2004 Apr;103(7):2648-54.
-
2003Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN, J. Virol. 2003 May;77(9):5313-23.
-
2003DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2, J. Biol. Chem. 2003 May;278(22):20358-66.
-
2002HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread, Immunity 2002 Jan;16(1):145-55.